FDA approves new Alzheimer’s treatment, donanemab from Eli Lilly
The Food and Drug Administration on Tuesday approved a new Alzheimer’s treatment called donanemab, paving the way for the third […]
Lilly
Novo, Lilly Slip as Biden Calls for Lower Obesity Drug Prices
(Bloomberg) — Shares of Novo Nordisk A/S and Eli Lilly & Co. fell on Tuesday after US President Joe Biden